Collagenase-based Solutions for Industrial and Environmental Applications

Publication ID: 24-11857685_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Collagenase-based Solutions for Industrial and Environmental Applications,” Published Technical Disclosure No. 24-11857685_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857685_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,685.

Summary of the Inventive Concept

The inventive concept leverages the core technology of collagenase-based treatment for uterine fibroids to address unmet needs in various industries, including paper production, textile manufacturing, soil erosion prevention, industrial equipment maintenance, and biofuel generation.

Background and Problem Solved

The original patent disclosed a method for treating uterine fibroids using purified collagenase. However, the potential applications of collagenase extend far beyond medical treatments. This inventive concept addresses the limitations of the original patent by exploring new use cases for collagenase in industrial and environmental contexts, where its unique properties can provide significant benefits.

Detailed Description of the Inventive Concept

The new claims describe various systems, methods, and compositions that utilize collagenase to break down and recycle cellulose fibers in waste paper, degrade and recycle keratin-based materials, stabilize soil particles, remove stubborn deposits of collagen-rich substances, and convert collagen-rich biomass into fermentable sugars. These applications take advantage of collagenase's ability to selectively degrade collagen-rich materials, offering a sustainable and efficient solution for various industries.

Novelty and Inventive Step

The new claims introduce a novel and non-obvious application of collagenase-based technology, departing from the original patent's medical focus. The inventive step lies in recognizing the potential of collagenase to address specific challenges in industrial and environmental contexts, and developing tailored solutions to capitalize on this potential.

Alternative Embodiments and Variations

Alternative embodiments may include using different sources of collagenase, such as bacterial or fungal-derived enzymes, or combining collagenase with other enzymes or agents to enhance its effectiveness. Variations may also involve adapting the collagenase-based solutions for use in other industries, such as wastewater treatment or bioremediation.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including paper and pulp, textiles, construction, and bioenergy. The market for collagenase-based solutions is expected to grow as companies seek sustainable and efficient solutions to reduce waste, increase productivity, and promote environmental stewardship.

CPC Classifications

SectionClassGroup
A A61 A61K9/48
A A61 A61K9/0019
A A61 A61K9/0034
A A61 A61K9/1075
A A61 A61K38/43
A A61 A61K38/4886
A A61 A61K45/06
C C12 C12Y304/24003

Field of Art

Biotechnology and enzyme engineering, with expertise in protein biochemistry, industrial enzyme applications, and collagenase-based biotransformation technologies

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degree in biochemistry or biotechnology, familiar with enzyme characterization, industrial biotechnology applications, and cross-industry enzyme adaptation strategies

Obviousness Rationale

A skilled practitioner would recognize the fundamental enzymatic properties of collagenase from the source patent and understand its potential for broader applications beyond medical treatments. The core mechanism of collagen degradation is transferable across multiple technical domains, making the industrial and environmental variations predictable extensions of the original enzymatic technology. The PTD demonstrates systematic adaptation of a known enzymatic process to solve diverse technical challenges through routine engineering and application design.

Obvious Combinations & Variations

Source Patent Element
Collagenase composition with specific concentration ranges (0.25-2.0 mg/mL) for targeted tissue degradation
PTD Variation
Adapting collagenase concentration ranges for industrial material breakdown processes
Obviousness Reasoning
A PHOSITA would recognize that enzyme concentration optimization is a standard engineering technique, and the concentration ranges disclosed in the source patent provide a direct template for industrial application scaling
Source Patent Element
Delivery methods using needles, syringes, catheters for precise enzyme introduction
PTD Variation
Developing specialized delivery systems for industrial enzyme application in paper recycling and equipment maintenance
Obviousness Reasoning
Precise delivery mechanisms are a known technique in biotechnology, and transferring targeted introduction strategies from medical to industrial contexts represents a predictable design evolution
Source Patent Element
Specific collagenase sourcing from Clostridium histolyticum
PTD Variation
Exploring alternative collagenase sources including bacterial and fungal enzymes for broader industrial applications
Obviousness Reasoning
Enzyme sourcing variation is a routine practice in biotechnology, and a skilled practitioner would recognize multiple potential microbial sources for functionally similar collagenase enzymes
Source Patent Element
Selective collagen-rich tissue degradation mechanism
PTD Variation
Applying selective degradation principles to industrial processes like soil stabilization and biomass conversion
Obviousness Reasoning
The fundamental enzymatic mechanism of selective molecular breakdown is directly transferable across technical domains, representing an obvious extension of the original technological concept
35 U.S.C. § 103 Summary: Based on US Patent 11857685's disclosure of collagenase composition and degradation methods, the present publication demonstrates that the claimed industrial and environmental enzyme applications would have been obvious to a person having ordinary skill in biotechnology at the time of invention. The systematic adaptation of enzymatic principles across technical domains represents a predictable technological progression achievable through routine engineering and design optimization.

Original Patent Information

Patent NumberUS 11,857,685
TitleTreatment method and product for uterine fibroids using purified collagenase
Assignee(s)Duke University, BioSpecifics Technologies LLC